Rubus Idaeus Extract Composition for Selective Inflammation Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current anti-inflammatory drugs, such as NSAIDs, inhibit both pro-inflammatory and anti-inflammatory prostaglandins, leading to limited success in treating inflammation due to the complex nature of inflammation responses and the redundancy of inflammation-inducing molecules.

Innovation Solution

Extracts obtained from Rubus idaeus, particularly from its stems and/or leaves, using water and/or ethanol as solvents, exhibit potent anti-inflammatory activity by reducing the release of proinflammatory cytokines and inhibiting Granzyme B activity, which are effective in treating or preventing conditions like arthritis and joint swelling.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Object-affected harmful factors

If NSAIDs are used to reduce inflammation by blocking cyclooxygenase activity, then proinflammatory prostaglandins are inhibited, but antiinflammatory prostaglandins are also inhibited leading to limited treatment success

Engineering Contradiction:
Improveproinflammatory prostaglandinsVSAvoidtreatment success
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The patent extracts and isolates specific anti-inflammatory compounds (ellagitannins, flavonoids, phenolic compounds) from Rubus idaeus plant material. This extraction process separates the beneficial anti-inflammatory constituents from the rest of the plant matrix, allowing for targeted therapeutic application that avoids the non-selective inhibition caused by NSAIDs.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention applies the principle of local quality by targeting specific inflammatory pathways through selectively active compounds. The Rubus idaeus extract contains compounds that specifically inhibit proinflammatory mediators while preserving anti-inflammatory pathways, creating a localized and selective anti-inflammatory effect rather than broad-spectrum inhibition.

Inventive Principle:
Principle #3Local quality

2Object-affected harmful factors

If NSAIDs block cyclooxygenase enzymatic activity, then inflammation is reduced, but endogenous antiinflammatory response is blocked prolonging chronic inflammation

Engineering Contradiction:
ImproveinflammationVSAvoidchronic inflammation duration
Core Design Contradiction:
Object-affected harmful factorsVSDuration of action of stationary object

Solution Approach 1:

The patent converts the complex chemical composition of Rubus idaeus, which initially appears as a mixture of many compounds, into a beneficial therapeutic agent. The natural polyphenolic composition, including ellagitannins and flavonoids, works synergistically to reduce inflammation while simultaneously supporting endogenous anti-inflammatory mechanisms, effectively turning a potential complexity problem into a therapeutic advantage.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Solution Approach 2:

The invention changes the parameter of selectivity in anti-inflammatory action. Instead of non-selective cyclooxygenase inhibition, the Rubus idaeus extract modifies the inflammatory response through multiple compounds acting on different targets (cytokines, chemokines, inflammatory mediators), creating a multi-parameter approach that reduces inflammation without blocking protective anti-inflammatory pathways.

Inventive Principle:
Principle #35Parameter changes

3Object-affected harmful factors

If Rubus idaeus extract is used to treat inflammation, then proinflammatory cytokines are reduced and Granzyme B activity is inhibited, but the balance of antiinflammatory responses must be maintained

Engineering Contradiction:
Improveproinflammatory cytokinesVSAvoidantiinflammatory response balance
Core Design Contradiction:
Object-affected harmful factorsVSStability of the object's composition

Solution Approach 1:

The patent applies universality by utilizing a multi-component phytochemical system from Rubus idaeus that performs multiple functions simultaneously. The extract contains ellagitannins, flavonoids, and phenolic compounds that collectively exhibit antioxidant, anti-inflammatory, and immunomodulatory activities, allowing a single preparation to address multiple aspects of inflammatory pathology while maintaining physiological balance.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The Rubus idaeus extracts effectively reduce inflammation by inhibiting proinflammatory cytokines and Granzyme B, offering therapeutic benefits for conditions such as rheumatoid arthritis and osteoarthritis, while maintaining the balance of anti-inflammatory responses.

Implementation Method 1

the extract is obtained or obtainable using water and/or ethanol as the extraction solvent

Methodology Applied
Scientific EffectSolvation: Solvation

Implementation Method 2

contacting the ground particles with a solvent mixture

Methodology Applied
Scientific EffectDissolution: Solvation

Data Source

PatentEP3558334B1compositions
Publication Date: 2025.08.27 NATUREX SA
  • EP3558334B1 patent drawingFigure 1
  • EP3558334B1 patent drawingFigure 2
  • EP3558334B1 patent drawingFigure 3

AI summary

The present invention relates to an extract obtained from or obtainable from Rubus idaeus, a composition comprising an extract obtained from or obtainable from Rubus idaeus, processes for providing such an extract, and methods and uses relating to such extracts. In particular, the present invention relates to an extract or composition for use in treating or preventing inflammation, such as arthritis and joint inflammation.